| Citation: |
ZOU Yue, CHEN Xufeng. Application of extracorporeal membrane oxygenation in high-risk percutaneous coronary intervention without obvious shock[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 139-143. DOI: 10.7619/jcmp.20220164
|
Percutaneous coronary intervention (PCI) is a feasible strategy for vascular remodeling in high-risk coronary artery disease patients who are not suitable for surgery or refuse surgery. However, such high-risk patients are at higher risk of hemodynamic collapse during balloon inflating or complex procedures, especially when coronary artery dissection with vessel closure or without re-flow occurs. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been introduced as a temporary mechanical circulatory support (MCS)for high-risk PCI, which can provide adequate systemic perfusion during surgery. This article reviewed the studies on the preventive use of extra-corporeal membrane oxygenation (ECMO) in technically complex high-risk PCI without obvious shock.
| [1] |
NEUMANN F J, SOUSA-UVA M, AHLSSON A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization[J]. Eur Heart J, 2019, 40(2): 87-165. doi: 10.1093/eurheartj/ehy394
|
| [2] |
THUIJS D J F M, KAPPETEIN A P, SERRUYS P W, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentrerandomised controlled SYNTAX trial[J]. Lancet, 2019, 394(10206): 1325-1334. doi: 10.1016/S0140-6736(19)31997-X
|
| [3] |
WALDO S W, SECEMSKY E A, O'BRIEN C, et al. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention[J]. Circulation, 2014, 130(25): 2295-2301. doi: 10.1161/CIRCULATIONAHA.114.011541
|
| [4] |
BOUKHRIS M, AZZARELLI S, TOMASELLO S D, et al. Diabetic patient with three-vessel disease and left main involvement. Surgery yes, but not always[J]. Egypt Heart J, 2015, 67(1): 83-87. doi: 10.1016/j.ehj.2014.11.004
|
| [5] |
AGGARWAL B, AMAN W, JEROUDI O, et al. Mechanical circulatory support in high-risk percutaneous coronary intervention[J]. Methodist Debakey Cardiovasc J, 2018, 14(1): 23-31. doi: 10.14797/mdcj-14-1-23
|
| [6] |
HUANG C C, HSU J C, WU Y W, et al. Implementation of extracorporeal membrane oxygenation before primary percutaneous coronary intervention may improve the survival of patients with ST-segment elevation myocardial infarction and refractory cardiogenic shock[J]. Int J Cardiol, 2018, 269: 45-50. doi: 10.1016/j.ijcard.2018.07.023
|
| [7] |
CHUNG S Y, TONG M S, SHEU J J, et al. Short-term and long-term prognostic outcomes of patients with ST-segment elevation myocardial infarction complicated by profound cardiogenic shock undergoing early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention[J]. Int J Cardiol, 2016, 223: 412-417. doi: 10.1016/j.ijcard.2016.08.068
|
| [8] |
韩宗茂, 高洁, 高传玉, 等. 早期血运重建及体外膜肺氧合支持治疗急性心肌梗死合并心原性休克的疗效观察及影响因素分析[J]. 中国循环杂志, 2021, 36(5): 433-438. doi: 10.3969/j.issn.1000-3614.2021.05.004
|
| [9] |
RIHAL C S, NAIDU S S, GIVERTZ M M, et al. 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American heart assocation, the cardiological society of India, and sociedad Latino Americana de cardiologiaintervencion; affirmation of value by the Canadian association of interventional cardiology-association canadienne de cardiologie d'intervention[J]. J Am Coll Cardiol, 2015, 65(19): e7-e26. doi: 10.1016/j.jacc.2015.03.036
|
| [10] |
THIELE H, ZEYMER U, NEUMANN F J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock[J]. N Engl J Med, 2012, 367(14): 1287-1296. doi: 10.1056/NEJMoa1208410
|
| [11] |
O'NEILL W W, KLEIMAN N S, MOSES J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2. 5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT Ⅱ study[J]. Circulation, 2012, 126(14): 1717-1727. doi: 10.1161/CIRCULATIONAHA.112.098194
|
| [12] |
PERERA D, STABLES R, CLAYTON T, et al. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention[J]. Circulation, 2013, 127(2): 207-212. doi: 10.1161/CIRCULATIONAHA.112.132209
|
| [13] |
BURZOTTA F, RUSSO G, BASILE E, et al. How to choose between intra-aortic balloon pump, Impella and extracorporeal membrane oxygenation[J]. G Ital Cardiol (Rome), 2018, 19(6 Suppl 1): 5S-13S.
|
| [14] |
韩雅玲. 中国经皮冠状动脉介入治疗指南2012(简本)[J]. 中华危重症医学杂志: 电子版, 2012, 5(3): 169-180. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWZD201203006.htm
|
| [15] |
TEIRSTEIN P S, VOGEL R A, DORROS G, et al. Prophylactic versus standby cardiopulmonary support for high risk percutaneous transluminal coronary angioplasty[J]. J Am Coll Cardiol, 1993, 21(3): 590-596. doi: 10.1016/0735-1097(93)90089-J
|
| [16] |
TAUB J O, L'HOMMEDIEU B D, RAITHEL S C, et al. Extracorporeal membrane oxygenation for percutaneous coronary angioplasty in high risk patients[J]. ASAIO Trans, 1989, 35(3): 664-666. doi: 10.1097/00002216-198907000-00161
|
| [17] |
SHAMMAS N W, ROBERTS S, EARLY G. Extracorporeal membrane oxygenation for unprotected left main stenting in a patient with totally occluded right coronary artery and severe left ventricular dysfunction[J]. J Invasive Cardiol, 2002, 14(12): 756-759.
|
| [18] |
VAINER J, VAN OMMEN V, MAESSEN J, et al. Elective high-risk percutaneous coronary interventions supported by extracorporeal life support[J]. Am J Cardiol, 2007, 99(6): 771-773. doi: 10.1016/j.amjcard.2006.10.034
|
| [19] |
GALASSI A R, GANYUKOV V, TOMASELLO S D, et al. Successful antegrade revascularization by the innovation of composite core dual coil in a three-vessel total occlusive disease for cardiac arrest patient using extracorporeal membrane oxygenation[J]. Eur Heart J, 2014, 35(30): 2009. doi: 10.1093/eurheartj/ehu070
|
| [20] |
KASS M, MOON M, VO M, et al. Awake extracorporeal membrane oxygenation for very high-risk coronary angioplasty[J]. Can J Cardiol, 2015, 31(2): 227. e11-227. e13. doi: 10.1016/j.cjca.2014.11.004
|
| [21] |
TOMASELLO S D, BOUKHRIS M, GANYUKOV V, et al. Outcome of extracorporeal membrane oxygenation support for complex high-risk elective percutaneous coronary interventions: a single-center experience[J]. Heart Lung, 2015, 44(4): 309-313. doi: 10.1016/j.hrtlng.2015.03.005
|
| [22] |
SHAUKAT A, HRYNIEWICZ-CZENESZEW K, SUN B, et al. Outcomes of extracorporeal membrane oxygenation support for complex high-risk elective percutaneous coronary interventions: a single-center experience and review of the literature[J]. J Invasive Cardiol, 2018, 30(12): 456-460.
|
| [23] |
BRSCIC E, ROVERO G, TESTA K, et al. In-hospital and mid-term outcomes of ECMO support during coronary, structural, or combined percutaneous cardiac intervention in high-risk patients - A single-center experience[J]. Cardiovasc Revasc Med, 2021, 32: 63-67. doi: 10.1016/j.carrev.2020.12.020
|
| [24] |
VAN DEN BRINK F S, MEIJERS T A, HOFMA S H, et al. Prophylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention[J]. Neth Heart J, 2020, 28(3): 139-144. doi: 10.1007/s12471-019-01350-8
|
| [25] |
LI Y N, YAN S J, GAO S Z, et al. Effect of an intra-aortic balloon pump with venoarterial extracorporeal membrane oxygenation on mortality of patients with cardiogenic shock: a systematic review and meta-analysis[J]. Eur J Cardiothorac Surg, 2019, 55(3): 395-404. doi: 10.1093/ejcts/ezy304
|
| [26] |
VALLABHAJOSYULA S, O'HORO J C, ANTHARAM P, et al. Venoarterial extracorporeal membrane oxygenation with concomitant impella versus venoarterial extracorporeal membrane oxygenation for cardiogenic shock[J]. ASAIO J, 2020, 66(5): 497-503. doi: 10.1097/MAT.0000000000001039
|
| [27] |
TRUBY L K, TAKEDA K, MAURO C, et al. Incidence and implications of left ventricular distention during venoarterial extracorporeal membrane oxygenation support[J]. ASAIO J, 2017, 63(3): 257-265. doi: 10.1097/MAT.0000000000000553
|
| [28] |
ORTUNO S, DELMAS C, DIEHL J L, et al. Weaning from veno-arterial extra-corporeal membrane oxygenation: which strategy to use[J]. Ann Cardiothorac Surg, 2019, 8(1): E1-E8. doi: 10.21037/acs.2018.08.05
|
| [29] |
高国栋, 龙村, 胡强, 等. 体外膜肺氧合支持治疗期间机体凝血功能的动态变化[J]. 实用临床医药杂志, 2015, 19(9): 9-11, 17. doi: 10.7619/jcmp.201509003
|
| [30] |
MCCARTHY F H, MCDERMOTT K M, SPRAGAN D, et al. Unconventional volume-outcome associations in adult extracorporeal membrane oxygenation in the United States[J]. Ann Thorac Surg, 2016, 102(2): 489-495. doi: 10.1016/j.athoracsur.2016.02.009
|
| [31] |
AISSAOUI N, EL-BANAYOSY A, COMBES A. How to wean a patient from veno-arterial extracorporeal membrane oxygenation[J]. Intensive Care Med, 2015, 41(5): 902-905. doi: 10.1007/s00134-015-3663-y
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: